Cerebral Review
✓ Updated July 2026
By the TelehealthIndex Editorial Team · How we score Good · #6 in Mental Health & Therapy
By the TelehealthIndex Editorial Team · Advertising Disclosure: TelehealthIndex is reader-supported. If you sign up with a
provider through links on this page, we may earn a commission at no extra cost to you.
Commissions never influence our scores or rankings — several of our top-rated providers pay
us nothing. How we score → · Full disclosure →
62.7/100
Cerebral score
Good · #6 in Mental Health & Therapy · Data as of July 2026
Clinical credibilityWeak
Regulatory & safety recordNotable deductions
Transparency & trustLimited
Access & coverageExceptional
Customer experienceGood
Value & pricingMixed
Pillar ratings are qualitative summaries of our internal rubric; we do not publish the
point weights. Read the full methodology →
TelehealthIndex scores and rankings are editorial opinions resulting from our selection, weighting, and interpretation of the factors described in our methodology.
What it is
Therapy + psychiatry (no controlled substances since Oct 2022); insurance pivot 2024-25; heavy 2022-2024 enforcement history.
Strengths
- In-network with insurance
- Available nationwide (50 states)
Considerations
- FTC 2024 order: $15M judgment, partially suspended (~$7M payable - $2M civil penalty + $5.1M consumer refunds), for sharing 3.18M consumers' health data + cancellation practices; banned from using health data for ads
- 2022 DOJ/DEA investigation resolved via Nov 2024 non-prosecution agreement ($3.65M forfeiture)
- 2023 pixel breach (3.18M people)
- If listed, flag prominently per methodology
Founded2020
OwnershipPrivate (SoftBank et al.)
AvailabilityNationwide (50 states)
InsuranceYes
Money-back guaranteeNot advertised
PricingPsychiatry ~$60/mo; therapy $175/session; med+therapy ~$365/mo; insurance copays
Visit Cerebral
We may earn a commission — disclosure.
If you are in crisis, call or text 988 (Suicide & Crisis Lifeline), available 24/7.
In a medical emergency, call 911. Nothing on this page is medical advice.
Alternatives to consider
Sources
- FTC press release: proposed order against Cerebral over sensitive-data disclosure and cancellation practices (Apr 15, 2024)
- U.S. Attorney's Office (E.D.N.Y.) press release: Cerebral non-prosecution agreement, $3.652M forfeiture (Nov 4, 2024)
Every regulatory claim on this page is cited to its primary source (or the issuing agency's database). Verified against the cited document; see our Editorial Policy.
Data as of July 19, 2026. Scores are editorial opinions reflecting documented business practices, transparency, pricing, access, and nonclinical consumer-service factors — not clinical quality or outcomes. Found an error? Report it →